Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Treasury Shares (2021)

Historic Treasury Shares for Coeptis Therapeutics Holdings (COEPW) over the last 1 years, with Q4 2021 value amounting to $247165.0.

  • Coeptis Therapeutics Holdings' Treasury Shares changed N/A to $247165.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $247165.0, marking a year-over-year change of. This contributed to the annual value of $247165.0 for FY2021, which is N/A changed from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Treasury Shares stood at $247165.0 for Q4 2021.
  • Coeptis Therapeutics Holdings' Treasury Shares' 5-year high stood at $247165.0 during Q4 2021, with a 5-year trough of $247165.0 in Q4 2021.